1. Home
  2. IRWD

IRWD

Ironwood Pharmaceuticals Inc.

Logo Ironwood Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-24-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Founded: 1998 Country:
United States
United States
Employees: N/A City: BOSTON
Market Cap: 1.3B IPO Year: 2010
Target Price: $19.50 AVG Volume (30 days): 4.6M
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -6.45 EPS Growth: N/A
52 Week Low/High: $7.79 - $15.70 Next Earning Date: 05-02-2024
Revenue: $442,735,000 Revenue Growth: 7.83%
Revenue Growth (this year): 3.27% Revenue Growth (next year): 8.91%

Share on Social Networks:

Stock Insider Trading Activity of Ironwood Pharmaceuticals Inc. (IRWD)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Duane Jon R IRWD Director Mar 6 '24 Buy $8.70 6,920 $60,204.00 121,028 SEC Form 4
Silver Ronald IRWD Principal Accounting Officer Feb 12 '24 Sell $15.24 7,908 $120,517.92 134,264 SEC Form 4
Shetzline Michael IRWD CMO,SVP,Head-Res&Drug Feb 12 '24 Sell $15.24 38,618 $588,538.32 340,484 SEC Form 4